We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.8B
AUM Growth
+$1.89B
Cap. Flow
+$423M
Cap. Flow %
1.85%
Top 10 Hldgs %
15.02%
Holding
3,143
New
326
Increased
869
Reduced
968
Closed
274

Sector Composition

Rank Sector Weight
1 Healthcare 16.59%
2 Technology 15.59%
3 Financials 13.54%
4 Industrials 10.36%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYOU
2226
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$1K ﹤0.01%
30
AVP
2227
DELISTED
Avon Products, Inc.
AVP
$1K ﹤0.01%
528
-123
-19% -$365
CRR
2228
DELISTED
Carbo Ceramics Inc.
CRR
$1K ﹤0.01%
219
VSI
2229
DELISTED
Vitamin Shoppe Inc.
VSI
$1K ﹤0.01%
+285
New +$2.2K
ACET
2230
DELISTED
Aceto Corp
ACET
$1K ﹤0.01%
164
AFSI
2231
DELISTED
AmTrust Financial Services, Inc.
AFSI
$1K ﹤0.01%
106
-70,159
-100% -$989K
PF
2232
DELISTED
Pinnacle Foods, Inc.
PF
$1K ﹤0.01%
+20
New +$1.19K
ONCY
2233
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$1K ﹤0.01%
2,000
FNM
2234
DELISTED
FANNIE MAE
FNM
$1K ﹤0.01%
350
HIBB
2235
DELISTED
Hibbett, Inc. Common Stock
HIBB
$1K ﹤0.01%
74
-3,165
-98% -$46.9K
PDLI
2236
DELISTED
PDL BioPharma, Inc.
PDLI
$1K ﹤0.01%
393
ABEO icon
2237
Abeona Therapeutics
ABEO
$345M
-80
Closed -$10K
AEO icon
2238
American Eagle Outfitters
AEO
$2.85B
-2,031,483
Closed -$28.4M
AIRG icon
2239
Airgain
AIRG
$74.3M
-145
Closed -$2K
AMSF icon
2240
AMERISAFE
AMSF
$569M
-6,928
Closed -$449K
AMWD
2241
DELISTED
American Woodmark
AMWD
-51
Closed -$4K
ANIP icon
2242
ANI Pharmaceuticals
ANIP
$1.77B
-398,691
Closed -$19.7M
APO icon
2243
Apollo Global Management
APO
$70.7B
-910
Closed -$22K
APVO icon
2244
Aptevo Therapeutics
APVO
$5.47M
0
AQB icon
2245
AquaBounty Technologies
AQB
$4.68M
0
ARAY icon
2246
Accuray
ARAY
$28.4M
-765
Closed -$3K
ARKR icon
2247
Ark Restaurants
ARKR
$0 ﹤0.01%
15
-1,031
-99% -$24.1K
AROC icon
2248
Archrock
AROC
$6.33B
-22,925
Closed -$284K
ATRC icon
2249
AtriCure
ATRC
$1.77B
-85
Closed -$1K
BCRX icon
2250
BioCryst Pharmaceuticals
BCRX
$2.37B
-200
Closed -$1K

Similar funds

Glenmede Trust's Q3 2017 Portfolio in Review

As of Q3 2017, Glenmede Trust held 3,143 positions worth $22.8B, up 9% from $20.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust's Q3 2017 filing shows 326 new, 869 increased, 968 reduced and 274 closed positions. Its largest new stake was Five Below: 1,137,870 shares worth $62.4M. The largest sale was Du Pont De Nemours E I, an estimated $91.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Glenmede Trust's largest Q3 2017 buy was Five Below: 1,137,870 shares worth $62.4M.
  • Glenmede Trust added most to Constellation Brands in Q3 2017, an estimated $125M increase.
  • Glenmede Trust's biggest Q3 2017 reduction was Tyson Foods, cutting an estimated $72.4M.
  • Glenmede Trust fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $91.2M.
  • Glenmede Trust's ten largest holdings make up 15% of its $22.8B portfolio in Q3 2017.
  • Glenmede Trust opened 326 new positions and closed 274 in Q3 2017.
  • Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $22.8B.

Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.